Trial Profile
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients With Essential Blepharospasm
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm
- Focus Therapeutic Use
- Sponsors Medytox
- 18 Jul 2017 New trial record